F Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ford Motor Co is not a strong buy for a beginner investor with a long-term focus at this time. The company's recent financial performance is weak, with significant declines in revenue, net income, and EPS. While insider buying and potential defense sector collaborations are positive catalysts, the lack of strong technical signals, mixed analyst ratings, and weak financials suggest holding off on investment until stronger signs of recovery or growth emerge.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 62.098, and moving averages are converging, showing no clear trend. Key support is at 11.542, and resistance is at 12.615. The stock is trading near its pivot level of 12.078, suggesting limited upside in the short term.
Insider buying has increased significantly by 1850.27% over the last month.
Potential collaboration with U.S. defense officials for military production could open new revenue streams.
UBS upgraded Ford to Buy, citing a credible path to higher earnings per share by 2027.
Weak financial performance in Q4 2025, with revenue down 4.81% YoY, net income down 706.58% YoY, and EPS down 717.78% YoY.
Mixed analyst ratings with several firms lowering price targets, citing macroeconomic concerns and weak auto sales in key markets like China.
The stock has a 50% chance of declining by -3.68% in the next month based on historical patterns.
Ford's Q4 2025 financials were weak, with revenue dropping to $45.89 billion (-4.81% YoY), net income plummeting to -$11.06 billion (-706.58% YoY), EPS falling to -2.78 (-717.78% YoY), and gross margin decreasing to 1.34 (-83.87% YoY).
Analyst ratings are mixed. UBS upgraded Ford to Buy with a $15 price target, citing long-term growth potential. However, Goldman Sachs, RBC Capital, and Wells Fargo lowered price targets to $13, $11, and $10, respectively, citing weak Q1 auto sales, rising input costs, and geopolitical risks. TD Cowen maintains a Hold rating, and JPMorgan remains optimistic with a $15 price target, citing reduced emissions compliance costs.
